These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 24134219)

  • 1. Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up.
    Persson I; Granath F; Askling J; Ludvigsson JF; Olsson T; Feltelius N
    J Intern Med; 2014 Feb; 275(2):172-90. PubMed ID: 24134219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contradictory data on type 1 diabetes in a recently published article 'Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up' (J Intern Med 2013).
    Andersson L
    J Intern Med; 2014 Oct; 276(4):414-7. PubMed ID: 24698654
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to second letter-to-the-editor by Lars Andersson: contradictory data on type 1 diabetes in a recently published article 'risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up'.
    Persson I
    J Intern Med; 2015 Feb; 277(2):274-275. PubMed ID: 25346073
    [No Abstract]   [Full Text] [Related]  

  • 4. Response on the author's reply to the letter to the editor: Contradictory data on type 1 diabetes in a recently published article "Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix".
    Andersson L
    J Intern Med; 2015 Feb; 277(2):272-273. PubMed ID: 25359510
    [No Abstract]   [Full Text] [Related]  

  • 5. Change in risk for narcolepsy over time and impact of definition of onset date following vaccination with AS03 adjuvanted pandemic A/H1N1 influenza vaccine (Pandemrix) during the 2009 H1N1 influenza pandemic.
    Granath F; Gedeborg R; Smedje H; Feltelius N
    Pharmacoepidemiol Drug Saf; 2019 Aug; 28(8):1045-1053. PubMed ID: 31062443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A scientific sequel to Stieg Larsson: relationship between Pandemrix--pandemic influenza vaccine--and the subsequent development of narcolepsy.
    Fugger L; Steinman L
    J Intern Med; 2014 Feb; 275(2):195-7. PubMed ID: 24286291
    [No Abstract]   [Full Text] [Related]  

  • 7. A coordinated cross-disciplinary research initiative to address an increased incidence of narcolepsy following the 2009-2010 Pandemrix vaccination programme in Sweden.
    Feltelius N; Persson I; Ahlqvist-Rastad J; Andersson M; Arnheim-Dahlström L; Bergman P; Granath F; Adori C; Hökfelt T; Kühlmann-Berenzon S; Liljeström P; Maeurer M; Olsson T; Örtqvist Å; Partinen M; Salmonson T; Zethelius B
    J Intern Med; 2015 Oct; 278(4):335-53. PubMed ID: 26123389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010.
    Lind A; Ramelius A; Olsson T; Arnheim-Dahlström L; Lamb F; Khademi M; Ambati A; Maeurer M; Nilsson AL; Bomfim IL; Fink K; Lernmark Å
    J Autoimmun; 2014 May; 50():99-106. PubMed ID: 24485154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns.
    Wijnans L; Lecomte C; de Vries C; Weibel D; Sammon C; Hviid A; Svanström H; Mølgaard-Nielsen D; Heijbel H; Dahlström LA; Hallgren J; Sparen P; Jennum P; Mosseveld M; Schuemie M; van der Maas N; Partinen M; Romio S; Trotta F; Santuccio C; Menna A; Plazzi G; Moghadam KK; Ferro S; Lammers GJ; Overeem S; Johansen K; Kramarz P; Bonhoeffer J; Sturkenboom MC
    Vaccine; 2013 Feb; 31(8):1246-54. PubMed ID: 23246544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Narcolepsy after AS03 Adjuvanted Pandemic A/H1N1 2009 Influenza Vaccine in Adults: A Case-Coverage Study in England.
    Stowe J; Andrews N; Kosky C; Dennis G; Eriksson S; Hall A; Leschziner G; Reading P; Shneerson JM; Donegan K; Miller E
    Sleep; 2016 May; 39(5):1051-7. PubMed ID: 26856903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of an association between onset of narcolepsy and vaccination with pandemic influenza vaccine, Ireland April 2009-December 2010.
    O'Flanagan D; Barret AS; Foley M; Cotter S; Bonner C; Crowe C; Lynch B; Sweeney B; Johnson H; McCoy B; Purcell E
    Euro Surveill; 2014 May; 19(17):15-25. PubMed ID: 24821121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza and risk of later celiac disease: a cohort study of 2.6 million people.
    Kårhus LL; Gunnes N; Størdal K; Bakken IJ; Tapia G; Stene LC; Håberg SE; Mårild K
    Scand J Gastroenterol; 2018 Jan; 53(1):15-23. PubMed ID: 29076383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden.
    Bardage C; Persson I; Ortqvist A; Bergman U; Ludvigsson JF; Granath F
    BMJ; 2011 Oct; 343():d5956. PubMed ID: 21994316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Narcolepsy and hypersomnia in Norwegian children and young adults following the influenza A(H1N1) 2009 pandemic.
    Trogstad L; Bakken IJ; Gunnes N; Ghaderi S; Stoltenberg C; Magnus P; Håberg SE
    Vaccine; 2017 Apr; 35(15):1879-1885. PubMed ID: 28302408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous reporting of suspected narcolepsy after vaccination against pandemic influenza A (H1N1) in Germany.
    Oberle D; Pavel J; Keller-Stanislawski B
    Pharmacoepidemiol Drug Saf; 2017 Nov; 26(11):1321-1327. PubMed ID: 28809087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No Evidence for Disease History as a Risk Factor for Narcolepsy after A(H1N1)pdm09 Vaccination.
    Lamb F; Ploner A; Fink K; Maeurer M; Bergman P; Piehl F; Weibel D; Sparén P; Dahlström LA
    PLoS One; 2016; 11(4):e0154296. PubMed ID: 27120092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reassessment of the risk of narcolepsy in children in England 8 years after receipt of the AS03-adjuvanted H1N1 pandemic vaccine: A case-coverage study.
    Stowe J; Andrews N; Gringras P; Quinnell T; Zaiwalla Z; Shneerson J; Miller E
    PLoS Med; 2020 Sep; 17(9):e1003225. PubMed ID: 32926731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis.
    Miller E; Andrews N; Stellitano L; Stowe J; Winstone AM; Shneerson J; Verity C
    BMJ; 2013 Feb; 346():f794. PubMed ID: 23444425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A.
    Heier MS; Gautvik KM; Wannag E; Bronder KH; Midtlyng E; Kamaleri Y; Storsaeter J
    Sleep Med; 2013 Sep; 14(9):867-71. PubMed ID: 23773727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Narcolepsy patients' blood-based miRNA expression profiling: miRNA expression differences with Pandemrix vaccination.
    Mosakhani N; Sarhadi V; Panula P; Partinen M; Knuutila S
    Acta Neurol Scand; 2017 Nov; 136(5):462-469. PubMed ID: 28251619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.